Gene Polymorphism
A sthma and its phenotypes are complex traits induced by interactions between the surrounding environment and multiple disease susceptibility factors. 1 Asthma has been recognized as a T-helper (Th) type 2-related disease with a cytokine response profile that includes interleukin (IL)-4, IL-5, and IL-13. 2, 3 These cytokines play an important role in the coordination and persistence of the airway inflammatory process in asthma patients. 4 Treatment with or transgenic expression of IL-17E (IL-25) in mice was found to induce Th2-type cytokines, notably IL-5 and IL-13, and chemokines, such as eotaxin (CCL11), along with eosinophilia, elevated levels of IgE, mucus secretion, and airway hyperreactivity (AHR). [5] [6] [7] Furthermore, the blockade of IL-25 in an experimental model of allergic asthma prevented AHR. 8 
IL-25R, which is also called IL-17 receptor B (IL-17RB) IL-17Rh1, and
Evi27, is a 56-kd single-transmembrane protein with homology to IL-17R. Th2 cytokines induce the expression of IL-17RB in antigen-presenting cells. 9 The activation of IL-17RB induces activation of Jun kinase (or JNK), p38 mitogen-activated protein kinase (or MAPK), and nuclear factor-B, 10 which regulate the expression of the genes responsible for the inflammatory and remodeling processes in asthma. 11 Létuvé et al 12 have demonstrated that human primary lung fibroblasts constitutively express IL-17BR. This suggests that the IL-17E derived from Th2 T cells, mast cells, and epithelial cells is capable of amplifying allergic-type inflammatory responses through its effect on other cell types via IL-17RB. 13, 14 Human IL-17RB (mendelian inheritance in man No. 605458) is located on chromosome 3p21.1. 15 The region around chromosome 3p21 is associated with the risk of asthma 16 and atopy. 17 Given the biological effects of IL-17RB and its linkage to chromosome 3p21, genetic variants of IL-17RB may play a role in Th2-mediated immune reactions, including asthma.
Materials and Methods

Subjects
Subjects were recruited from the Genome Research Center for Allergy and Respiratory Diseases at Soonchunhyang University, Bucheon, Seoul, Korea, and Chunan Hospital, Chunan, Korea. All patients had received a diagnosis of asthma by a physician and met the definition of asthma set forth in the Global Initiative for Asthma guidelines. 18 All patients had a history of dyspnea and wheezing during the previous 12 months plus one of the following: (1) a Ͼ 15% increase in FEV 1 or a Ͼ 12% increase plus 200 mL after the inhalation of a short-acting bronchodilator; (2) a provocative concentration of methacholine causing a 20% fall in FEV 1 (PC 20 ) of Ͻ 10 mg/mL; and (3) a Ͼ 20% increase in FEV 1 after 2 weeks of treatment with inhaled steroids and long-acting bronchodilators. The healthy subjects were recruited from the spouses of the patients and from members of the general population who answered negatively to a screening questionnaire for respiratory symptoms 19 and had an FEV 1 of Ͼ 75% predicted, a PC 20 of Ͼ 10 mg/mL, and normal findings on a simple chest radiogram. Twenty-four common inhaled allergens (eg, dust mites ͓Dermatophagoides farinae and Dermatophagoides pteronyssinus͔, cat fur, dog fur, cockroaches, grasses, trees, and ragweed pollen) were used for a skin-prick test. Total IgE level was measured (ImmunoCAP System; Pharmacia Diagnostics; Uppsala, Sweden). Atopy was defined as having a wheal reaction equal to or greater than that from histamine or 3 mm in diameter. The subjects and study protocols were approved by the Institutional Review Board of Soonchunhyang University Hospital.
Sequence Analysis of Human IL-17RB
The entire IL-17RB gene, including the promoter region (approximately 1.5 kb), was sequenced from 24 DNA samples to identify single-nucleotide polymorphisms (SNPs) ͓ABI PRISM 3700 DNA Analyzer; Applied Biosystems; Foster City, CA͔. The primer sets used for amplification and sequencing were designed based on sequence information from GenBank (NC_000003). Information regarding the primers is given online in supplementary Table 1 (http://www.snpgenetics.com/user/additional_list.asp).
Genotyping of IL-17RB Polymorphisms
Among the 18 polymorphisms discovered, six (Ϫ1465GϾA in the promoter, ϩ5661GϾA in intron 4, ϩ6297TϾC ͓Y123Y͔ in exon 5, ϩ13797CϾT in intron 10, and ϩ18661CϾT and ϩ18965GϾA in the 3Ј-UTR) were selected based on the following general criteria: Ͼ10% of the minor allele frequency and a polymorphism among tight linkage disequilibriums (LDs) ͓DЈ ϭ1; r 2 Ͼ 0.85͔ (supplementary Tables 2 and 3 ͓http://www.snp-genetics.com/user/additional_ list.asp͔). For the purpose of genotyping the six SNPs, TaqMan primers and probes were designed. 20 A design system (Primer Express; Applied Biosystems) was used to design both the polymerase chain reaction (PCR) primers and MGB TaqMan probes (supplementary Table 4 ). One allelic probe was labeled with 6-carboxyfluorescein dye, whereas the other was labeled with the fluorescent dye VIC (Perkin-Elmer Applied Biosystems). PCRs were run using TaqMan Universal Master Mix (Applied Biosystems) containing PCR primers and TaqMan MGB probes. The reactions were performed in a 384-well format using a total reaction volume of 5 L with 20 ng of genomic DNA. The plates were then placed in a thermal cycler (PE 9700 Thermal Cycler; PerkinElmer; Waltham, MA) and heated to 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The plates were then transferred to a sequencer (Prism 7900HT Sequence Detection System; Applied Biosystems), and the fluorescence intensity was read. The fluorescence data were analyzed using automated software (SDS, version 2.1; Applied Biosystems). There were 24 samples used in a duplicate genotyping test for a positive control, and 12 blanks were used for a negative control. OH) and a modified version of the guanidium thiocyanate-phenol chloroform extraction method. 21 DNA contamination was eliminated by treatment with 1 L of RNase-free DNase I for 15 min at 37°C. The DNase I-treated RNA was then heated to 65°C for 5 min with 1 L of oligo-deoxythymidine-15 primer (500 g/mL) and 10 mmol/L deoxyribonucleoside triphosphates, then quickly chilled on ice. Pellets were incubated at 42°C for 2 min with 0.1 mmol/L dithiothreitol and 1 L (200 U/L) of a reverse transcriptase (SuperScript II Reverse Transcriptase; Invitrogen; Carlsbad, CA) at 42°C for 50 min, and then heat inactivated at 70°C for 15 min. After reverse transcription (RT), complementary DNA was dispensed into tubes containing primers specific for human IL-17RB and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes. The primer sequences were summarized in Table 2 . Amplification was performed using the following program: 30 cycles of 1 min at 95°C, 1 min at 52°C, and 1 min at 72°C, with an initial denaturation at 95°C for 3 min and a final extension at 72°C for 7 min. The amplified products (546 and 300 base pairs for IL-17RB and GAPDH, respectively) underwent electrophoresis on a 1% agarose gel and were visualized by ethidium bromide staining. The PCR products were then analyzed by direct sequencing using the PCR primers and an analyzer (ABI PRISM 3700 DNA Analyzer). The sequences were compared using the BLAST search program from the National Institutes of Health.
Semi-Quantitation of
Statistical Analysis
LD was measured as the Lewontin DЈ and r 2 . 22, 23 The haplotype of each individual was inferred using the EM algorithm (PHASE, version 2.0) developed by Stephens et al. 24 The association of the various IL-17RB genotypes and haplotypes with the risk of asthma was analyzed using logistic regression models, whereas controlling for age (continuous value), sex (male, 0; female, 1), smoking status (nonsmoker, 0; ex-smoker, 1; smoker, 2), and atopy (positive, 0; negative, 1) as covariates. All statistical analyses were performed using two statistical software packages (SAS, version 9.1; SAS Institute; Cary, NC; or SPSS, version 11; SPSS Inc; Chicago, IL). The p values were corrected for multiple comparisons using the Bonferroni correction test. The RT-PCR intensity data are expressed as the mean Ϯ SEM. The MannWhitney U test was applied to compare differences between samples. A p value Ͻ 0.05 was considered to be significant.
Results
Characteristics of the Study Subjects
The clinical characteristics of the study subjects are summarized in Table 1 . We found significant differences in mean age, prevalence of smoking, and prevalence of atopy between the healthy control subjects and asthmatic patients (p ϭ 0.001). FVC, FEV 1 , and PC 20 values were significantly lower in asthmatic patients than in healthy control subjects (p Ͻ 0.001). IgE levels and eosinophil numbers were significantly higher in asthmatic patients (p Ͻ 0.001).
Association of SNPs in IL-17RB With Risk of Asthma
Direct sequencing of 24 unrelated Korean DNA samples using 17 primer sets revealed 18 genetic variants (four insertion/deletions and 14 SNPs) within the exons and flanking regions of IL-17RB, as follows: four SNPs in the promoter region; one SNP in exon 5; eight intronic SNPs; and five SNPs in the 3Ј-UTR (Fig  1, top, A , and supplementary Table 2 ). Pairwise comparisons of the SNPs revealed three sets of absolute LDs (DЈ ϭ 1 and r 2 ϭ 1; ϩ2048AϾG:ϩ2065TinsϾ del, ϩ5552Tins/del:ϩ5661GϾA, and ϩ12288CϾT: ϩ18563TϾC); several complete LDs (DЈ ϭ 1 and r 2 1) were also found (Fig 1, bottom right, C) . Six SNPs were selected for large-scale genotyping. Haplotypes of IL-17RB were constructed using software (PHASE), and three major haplotypes with Ͼ 10% of minor allele frequency were used for further statistical analysis. The genotype distributions of the six SNPs were in Hardy-Weinberg equilibrium for all subjects (p Ͼ 0.05) ͓Table 3͔. The frequency of each of the six polymorphisms and three haplotypes was compared between the asthmatic patients and healthy control subjects using logistic regression. The allele frequencies in the asthmatic patients and healthy control subjects are shown in Table 4 . Among the six polymorphisms tested, one intronic polymorphism (ϩ5661GϾA) was significantly associated with the risk of asthma. %), unless otherwise indicated. rs ϭ reference SNP; C/C ϭ homozygote for common allele; C/R ϭ heterozygote; R/R ϭ homozygote for rare allele; C ϭ common allele; R ϭ rare allele; NC ϭ normal control; BA ϭ bronchial asthma. †Determined by 2 test. Table 3 for abbreviations not used in the text. Genotype distributions, and p values for regression analyses of three alternative models (codominant, dominant, and recessive models) are shown after controlling for age (continuous value), sex (male, 0; female, 1), atopy status (nonatopy, 0; atopy, 1), and smoking status (nonsmoker, 0; ex-smoker, 1; smoker, 2) as covariables.
The frequency of minor allele (ϪIL-17RBϩ 5661GϾA) in the asthmatic group was lower than that in the healthy control group (0.13 vs 0.19, respectively). The frequency of a rare allele (IL-17RBϩ5661GϾA) was significantly lower in the asthmatic patients, regardless of the analysis mode (codominant mode: odds ratio ͓OR͔, 0.62; p ϭ 0.001; dominant mode, OR, 0.62; p ϭ 0.002; recessive mode, OR, 0.34; p ϭ 0.018). After the Bonferroni correction, the difference remained significant (p ϭ 0.006 in the codominant mode; p ϭ 0.012 in the dominant mode). Thus, a rare allele of IL-17RBϩ5661GϾA may have a protective effect against the development of asthma.
Comparison of the Messenger RNA Expression of IL-17RB Between ϪIL-17RBϩ5661GG and AA Our pairwise comparisons revealed absolute LDs between ϩ5552T ins/del and ϩ5661GϾA in an intronic region; thus, we checked for the presence of alternative splicing in exons 2 to 7 using RT-PCR. The PCR products were then directly sequenced, and no isoforms were detected (Fig 2, top, A) . To investigate the genetic effect of the polymorphisms on the messenger RNA expression of IL-17RB in B cells, we used RT-PCR to measure the IL-17RB messenger RNA levels in B-cell lines derived from those subjects carrying ϩ5661GG and ϩ5661AA. Semi-quantitation of the IL-17RB messenger RNA level was done by measuring the intensity of the IL-17RB RT-PCR product after correcting for the intensity of GAPDH. The expression of IL-17RB was significantly increased in those lines that were homozygous for IL-17RBϩ5661GG (n ϭ 8) compared to those that were homozygous for IL-17RBϩ 5661AA (n ϭ 8; p ϭ 0.002) ͓Fig 2͔. Our results indicate that expression of the IL-17RB gene may be regulated at the transcriptional level based on the ϩ5661GϾA genotype.
Discussion
In the present study, we report the novel finding that an intronic polymorphism (ϩ5661GϾA), which is in absolute LD with one ins/del polymorphism (ϩ5552TinsϾdel), is significantly associated with the development of asthma (p ϭ 0.001). Whole-genome analyses have shown that chromosome region 3p21-24, which contains a gene cluster of CC chemokine receptors including CCR3, CCR2, and CCR5, is linked to asthma. 25 One genetic marker on chromosome 3p (D3S2409) was closely linked to the asthmatic phenotype in a founder population. 16 These results suggest that polymorphisms in IL-17RB have a genetic effect on the susceptibility of an individual to asthma. Genomic variation, in the form of single-nucleotide substitutions or small insertions and deletions, in intronic regions was not previously thought to change the sequence of a protein; however, some evidence indicates that such variation can cause splicing abnormalities, which may result in human disease. 26 To determine the genetic effect of IL-17RB ϩ5661GϾA or IL-17RB ϩ5552T insϾdel in intron 4 on splicing, we analyzed B-cell lines by RT-PCR using primers specific for exons 2 to 7. The products were then sequenced and confirmed as IL-17RB messenger RNA. Our results revealed no alternative form of IL-17RB in B-cell lines derived from those asthmatic subjects carrying either genotype of IL-17RB ϩ5661GϾA (Fig 2, top, A) . Considering that splicing abnormalities are often tissue specific, it is important to choose appropriate target cells. IL-17RB is not expressed in peripheral blood leukocytes, lymphoid organs, and most cell lines. IL-17RB, which is the receptor for IL-17E, is upregulated in inflammatory tissues but is not present at a high copy number on eosinophils or B cells. Because IL-17RB expression is limited to anti-CD3 and anti-CD28 antibody-costimulated memory Th cells, antigen-presenting cells, and cultured primary fibroblasts, 9, 12, 27, 28 no RT-PCR products were produced from the peripheral blood mononuclear cells of the asthmatic patients in the present study (data not shown). However, IL-17RB is up-regulated in numerous B, T, and myeloid leukemic cell lines, including M1 (myeloid leukemia), EL-4 (thymoma), and WEHI231 (pre-B-cell lymphoma). 29 This prompted us to use B-cell lines derived from the asthmatic patients for the semi-quantitative measurement of IL-17RB expression. The messenger RNA expression of IL-17RB in the B-cell lines was significantly higher in those cells that were homozygous for IL-17RB ϩ5661GG compared to those that were homozygous for IL-17RB ϩ5661AA (Fig 2) . These results indicate that the expression of the IL-17RB gene may be regulated at the transcriptional level based on the ϩ5661GϾA genotype.
IL-17RB binds strongly to IL-17E and weakly to IL-17B, but does not bind IL-17 or IL-17C. 30 The activation of IL-17RB induces Jun kinase, p38 mitogenactivated protein kinase, and nuclear factor-B activation, 10 and the production of monocyte chemotactic protein-1, monocyte inflammatory protein-1␣, IL-6, and IL-8 by eosinophils. 11 It was recently demonstrated 12 that human primary lung fibroblasts constitutively express IL-17RB and that IL-17E stimulates the production of the eosinophil-associated mediators CCL-5, CCL-11, granulocyte macrophage colony-stimulating factor, and CXCL-8. This indicates that IL-17E may contribute to the induction and maintenance of allergic inflammation in the airways via IL-17RB. In addition, the IL-17E produced by innate effector eosinophils and basophils may augment allergic inflammation by enhancing the maintenance and functions of adaptive Th2 memory cells. 13 The blockade of IL-25 in an experimental model of allergic asthma prevented AHR, which is a critical feature of clinical asthma. The administration of anti-IL-25 monoclonal antibodies during the sensitization phase resulted in significantly reduced levels of IL-5 and IL-13 production, eosinophil infiltration, goblet cell hyperplasia, and serum IgE, and prevented AHR. 8 Thus, genetic variants of IL-17RB may play a role in Th2-mediated immune reactions in asthmatic patients. It is currently unclear how an intronic polymorphism can induce a phenotypic change. IL-17RB ϩ5661GϾA and IL-17RB ϩ5552T insϾdel may induce exon skipping, enhance the use of cryptic splice sites, or alter the ratio of alternatively spliced isoforms. Further study is needed to elucidate the functions of these intronic variants.
In summary, we examined the genetic association of IL-17RB with the risk of asthma. Our results revealed that the IL-17RB ϩ5661GϾA locus has a dominant and protective genetic effect on the development of asthma. The results of this study may be helpful in understanding the function of polymorphisms in IL-17RB in asthma development and may lead to the production of new asthma drugs.
